How the SORLA protein in brain immune cells may shape Alzheimer's disease
Elucidating a microgliaassociated role for SORLA in modulating AD pathogenesis
Researchers are looking at whether changes in the SORLA protein inside brain immune cells (microglia) influence how Alzheimer's disease develops.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sanford Burnham Prebys Medical Discovery Institute NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-11297530 on NIH RePORTER |
What this research studies
This project makes human microglia-like cells from stem cells and edits them to carry Alzheimer's-linked SORL1 (SORLA) mutations so scientists can watch how the cells behave. They compare gene activity and how well these modified cells take up and clear amyloid-beta, a protein linked to Alzheimer's, and they also transplant the human cells into mouse brains to see plaque interactions. The team studies SORL1 changes alongside other Alzheimer's genes such as TREM2 and APOE to understand combined effects on microglial function. From a patient perspective, the work aims to explain why some genetic changes may make brain immune cells less able to remove harmful proteins.
Who could benefit from this research
Good fit: People with Alzheimer's disease, especially those known to carry SORL1, TREM2, or high-risk APOE variants, would be the most relevant group for future trials informed by this work.
Not a fit: People without Alzheimer's or whose dementia is caused by non-amyloid conditions are unlikely to see direct benefit from this laboratory-focused research in the near term.
Why it matters
Potential benefit: If successful, this could point to new ways to boost microglial clearance of amyloid or target SORLA-related pathways to slow or prevent Alzheimer's progression.
How similar studies have performed: Related lab and genetic studies linking microglial genes like TREM2 and APOE to Alzheimer's exist, but studying SORLA in human microglia is a newer and pioneering approach.
Where this research is happening
La Jolla, United States
- Sanford Burnham Prebys Medical Discovery Institute — La Jolla, United States (Active)
Researchers
- Principal investigator: Huang, Timothy Yikai — Sanford Burnham Prebys Medical Discovery Institute
- Study coordinator: Huang, Timothy Yikai
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.